BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for GlycoMimetics, Inc. (GLYC)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for GlycoMimetics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-01-29
4:31 pm
Unchanged		 2023-03-29 13G GlycoMimetics, Inc.
GLYC		 BIOTECHNOLOGY VALUE FUND L P 9,544,262
14.800%		 0
(Unchanged)		 Filing
2021-02-11
5:14 pm
Purchase		 2020-12-31 13G GlycoMimetics, Inc.
GLYC		 BIOTECHNOLOGY VALUE FUND L P 9,544,262
19.960%		 2,182,461increase
(+29.65%)		 Filing